Intimation Of Action Taken Or Order Passed By Regulatory Statutory Enforcement Authority Or Judicial Body Under Regulation 30 (Read With Part B Of Schedule III) (Listing Obligations And Disclosure Requirements) Regulations 2015
03-Jun-2026 | Source : BSEPlease find enclosed
Board Meeting Outcome for Outcome Of Board Meeting Held Today
21-May-2026 | Source : BSEPursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that the Board of Directors of our Company at their meeting held today i.e. 21st May 2026 has inter alia considered and approved the following: 1. Audited Standalone Financial Results of the Company for the quarter ended 31st March 2026 and Audited Financial Statements for the year ended on 31st March 2026 along with the Auditors Report thereon. We would like to state that M/s. Shah Shroff & Associates Statutory Auditors of the Company have issued audit report with unmodified opinion on the Statements. 2. Boards Report and its annexures Management Discussion Analysis (MDA) and Corporate Governance Report of the Company for the financial year ended on 31st March 2026. We wish to inform you that the Board Meeting commenced today at 5:00 P.M and concluded at 5:25 P.M.
Audited Standalone Financial Results Of The Company For The Quarter Ended 31St March 2026 And Audited Financial Statements For The Year Ended On 31St March 2026 Along With The AuditorS Report Thereon
21-May-2026 | Source : BSEPlease find enclosed
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
Medico Remedies Ltd has announced 2:10 stock split, ex-date: 16 Mar 23
Medico Remedies Ltd has announced 3:1 bonus issue, ex-date: 16 Nov 21
No Rights history available